Logo

JP Morgan

PerkinElmer Reaches Deal for $1.5B Credit Facility

The agreement is for a new credit facility, which replaces one from 2019 that provided for a $1 billion unsecured revolving credit facility.

JP Morgan, Cowen Initiate Coverage of Sophia Genetics With Overweight, Outperform Ratings

Both investment banks are bullish on the genomic data analysis firm, which went public on the Nasdaq a month ago, raising $234 million in gross proceeds.

PerkinElmer Enters $500M Credit Facility

The proceeds will be used to pay, in part, PerkinElmer's $5.25B acquisition of BioLegend, announced last month.

JP Morgan, Cowen Initiate Coverage of Singular Genomics Systems

Analysts estimated the total addressable market for the San Diego-based next-generation sequencing firm at between $44 billion and $50 billion.

Singular Genomics Ups IPO Target to $187M

The San Diego-based DNA sequencing startup plans to offer 8.5 million shares at an IPO price between $20 and $22 per share, for a $1.5 billion valuation.

May 12, 2021

Sequencing Startup Singular Genomics Files for $100M IPO

Feb 18, 2021

Infectious Disease Dx Firm Talis Biomedical Raises $254M in IPO

Jan 14, 2021

JP Morgan Healthcare Conference 2021, Day 3: Exact Sciences, Danaher, NanoString, Bio-Techne, More

Jan 13, 2021

JP Morgan Healthcare Conference 2021, Day 1: Qiagen, Invitae, Agilent, Sema4, More

Jan 13, 2021

At JPM, Natera CEO Lays Out Growth Potential for NIPT, Transplant, Cancer Testing

Jan 12, 2021

Hologic Looks to Expand Profile in Breast Cancer Testing With Biotheranostics Acquisition
Premium

Jan 12, 2021

JP Morgan Healthcare Conference 2021, Day 2: Roche, Seer, 10x, Guardant, Hologic, Thermo Fisher

Jan 11, 2021

PerkinElmer CEO Talks COVID-19, Long-Term Outlook at JP Morgan

Dec 3, 2020

Twist Bioscience Prices Upsized $300M Public Offering

Dec 2, 2020

Twist Bioscience Proposes $250M Public Offering

Nov 3, 2020

Pacific Biosciences Gears Up For Commercial, R&D Push With Eye Toward Collaborations
Premium

Oct 14, 2020

JP Morgan Rates Invitae Neutral

Oct 8, 2020

NanoString Technologies Prices $200M Public Offering

Oct 7, 2020

NanoString Technologies Q3 Preliminary Product, Service Revenues Grow 14 Percent

Oct 2, 2020

Pacific Biosciences Upgraded to Overweight by JP Morgan

Sep 21, 2020

Grail Deal Will Enable Illumina to Expand From Tech Innovator to Diagnostics Provider
Premium

Sep 21, 2020

JP Morgan Downgrades Illumina to Neutral on Grail Deal

Sep 11, 2020

10x Genomics Prices Upsized $440M Public Offering

Sep 9, 2020

10x Genomics to Sell 3.5M Shares in Public Offering

Aug 20, 2020

JP Morgan Assigns Overweight Ratings to Thermo Fisher, Qiagen

Breaking News
The Scan

Highly Similar

Researchers have uncovered bat viruses that are highly similar to SARS-CoV-2, according to Nature News.

Gain of Oversight

According to the Wall Street Journal, the Biden Administration is considering greater oversight of gain-of-function research.

Lasker for mRNA Vaccine Work

The Scientist reports that researchers whose work enabled the development of mRNA-based vaccines are among this year's Lasker Award winners

PLOS Papers on Causal Variant Mapping, Ancient Salmonella, ALK Fusion Test for NSCLC

In PLOS this week: MsCAVIAR approach to map causal variants, analysis of ancient Salmonella, and more.